Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Cannabis Bioscience International Holdings Market Cap?
Cannabis Bioscience International HoldingsCBIH +33.33% Market Cap is $2.33 Mil as of Aug. 03, 2026. The stock has 4 warning signs investors should review. Among 1,024 Drug Manufacturers companies, Cannabis Bioscience International Holdings ranks worse than 95.21% on this metric.
Cannabis Bioscience International Holdings's quarterly market cap
declined
from Aug. 2025 ($8.14 Mil) to Nov. 2025 ($5.81 Mil) and
declined
from Nov. 2025 ($5.81 Mil) to Feb. 2026 ($4.65 Mil).
Cannabis Bioscience International Holdings's annual market cap
increased
from May. 2023 ($5.03 Mil) to May. 2024 ($6.26 Mil) and
increased
from May. 2024 ($6.26 Mil) to May. 2025 ($6.98 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Cannabis Bioscience International Holdings's Enterprise Value for Today is $2.73 Mil.
Cannabis Bioscience International Holdings (OTCPK:CBIH) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Cannabis Bioscience International Holdings Market Cap Related Terms
Cannabis Bioscience International Holdings Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cannabis Bioscience International Holdings Market Cap Chart
Cannabis Bioscience International Holdings Annual Data
For the Drug Manufacturers - Specialty & Generic subindustry, Cannabis Bioscience International Holdings's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cannabis Bioscience International Holdings Market Cap vs Drug Manufacturers Industry
Cannabis Bioscience International Holdings Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cannabis Bioscience International Holdings (CBIH) has a Market Cap of $2.33 Mil as of Aug. 03, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Cannabis Bioscience International Holdings and its competitors. According to the industry distribution chart, Cannabis Bioscience International Holdings ranks #975 out of 1024 companies in the Drug Manufacturers industry, placing it in the top 95.2%.
Is Cannabis Bioscience International Holdings' Market Cap too high?
Cannabis Bioscience International Holdings' current Market Cap is $2.33 Mil. The Drug Manufacturers industry median Market Cap is 212.16. Cannabis Bioscience International Holdings' value of $2.33 Mil is 98.9% below this industry median. Based on the distribution chart, Cannabis Bioscience International Holdings ranks #975 out of 1024 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Cannabis Bioscience International Holdings' Market Cap compare to SXTC and UPC?
According to the Drug Manufacturers industry distribution chart, Cannabis Bioscience International Holdings ranks #975 out of 1024 companies for Market Cap. This places Cannabis Bioscience International Holdings in the lower half of its industry. The industry median Market Cap is 212.16. Cannabis Bioscience International Holdings' value of $2.33 Mil is 98.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 212.16, based on 1,024 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cannabis Bioscience International Holdings's current Market Cap of $2.33 Mil is 98.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Cannabis Bioscience International Holdings and its competitors. For the Drug Manufacturers industry, the median Market Cap is 212.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cannabis Bioscience International Holdings's current Market Cap is $2.33 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cannabis Bioscience International Holdings stock overvalued right now?
Cannabis Bioscience International Holdings (CBIH) has a current Market Cap of $2.33 Mil. The current Market Cap is $2.33 Mil and 98.9% below the Drug Manufacturers industry median of 212.16. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Cannabis Bioscience International Holdings (CBIH), the current Market Cap is $2.33 Mil as of Aug. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Cannabis Bioscience International Holdings Inc operates in three main areas. Firstly, the company engages in cannabis-related research and education under the trade name Pharmacology University. Secondly, it serves as both a Sponsor and a Contract Research Organization (CRO) in clinical trials, some of which involve cannabis and CBD products, under the trade name Alpha Research Institute. Lastly, the company plans to manufacture, market, and sell CBD products branded as "VitaCookies." The majority of the company's revenue comes from clinical trial contracts, while a smaller portion is generated from cannabis-related educational classes and seminars.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CBIH has been successfully added to your 
